221 related articles for article (PubMed ID: 35618871)
1. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution.
Kudo A; Yaguchi H; Tanaka K; Kimura A; Yabe I
J Neurol; 2024 Jan; 271(1):553-563. PubMed ID: 37610447
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.
Damato V; Papi C; Spagni G; Evoli A; Silvestri G; Masi G; Sabatelli E; Campetella L; McKeon A; Andreetta F; Riso V; Monte G; Luigetti M; Primiano G; Calabresi P; Iorio R
Eur J Neurol; 2022 Feb; 29(2):564-572. PubMed ID: 34710286
[TBL] [Abstract][Full Text] [Related]
4. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
5. [Cerebellar Ataxia and Autoantibodies].
Nanri K; Yoshikura N; Kimura A; Nakayama S; Otomo T; Shimohata T; Terashi H; Sato T; Yamada J
Brain Nerve; 2018 Apr; 70(4):371-382. PubMed ID: 29632285
[TBL] [Abstract][Full Text] [Related]
6. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
[TBL] [Abstract][Full Text] [Related]
7. [Immune-Mediated Cerebellar Ataxias].
Mitoma H
Brain Nerve; 2023 Jun; 75(6):737-747. PubMed ID: 37287357
[TBL] [Abstract][Full Text] [Related]
8. Immune Ataxias: The Continuum of Latent Ataxia, Primary Ataxia and Clinical Ataxia.
Manto M; Mitoma H
J Integr Neurosci; 2024 Apr; 23(4):79. PubMed ID: 38682229
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
10. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
11. Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.
Hadjivassiliou M; Manto M; Mitoma H
Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138901
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and relapsing factors of primary autoimmune cerebellar ataxia: a prospective cohort study.
Liu M; Ren H; Wang L; Fan S; Bai L; Guan H
J Neurol; 2024 Mar; 271(3):1072-1079. PubMed ID: 38141127
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
14. Neurological Autoimmunity Associated With Homer-3 Antibody: A Case Series From China.
Liu M; Ren H; Fan S; Zhang W; Xu Y; Zhao W; Guan H;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580182
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune cerebellar ataxia associated with anti-Purkinje cells antibodies: the next frontier of neuroimmunology.
Zhang W; Ren H; Ren X; Fang F; Guan H
Ann Transl Med; 2023 Apr; 11(7):285. PubMed ID: 37090052
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and prognosis of patients with anti-glutamic acid decarboxylase antibody-related cerebellar ataxia].
Bai L; Cai Y; Ren HT; Di WY; Liu MG; Fan SY; Guan HZ
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1935-1937. PubMed ID: 35768393
[TBL] [Abstract][Full Text] [Related]
17. Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.
Mitoma H; Adhikari K; Aeschlimann D; Chattopadhyay P; Hadjivassiliou M; Hampe CS; Honnorat J; Joubert B; Kakei S; Lee J; Manto M; Matsunaga A; Mizusawa H; Nanri K; Shanmugarajah P; Yoneda M; Yuki N
Cerebellum; 2016 Apr; 15(2):213-32. PubMed ID: 25823827
[TBL] [Abstract][Full Text] [Related]
18. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
[TBL] [Abstract][Full Text] [Related]
19. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
20. Nonparaneoplastic autoimmune cerebellar ataxias.
Joubert B; Honnorat J
Curr Opin Neurol; 2019 Jun; 32(3):484-492. PubMed ID: 30694927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
